HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of experimental fascioliasis on the pharmacokinetics of antipyrine and sulphadimidine in desert sheep.

Abstract
Healthy adult male desert sheep were experimentally infected with Fasciola gigantica, to investigate the influence of experimental fasciolasis on the pharmacokinetics of antipyrine and sulphadimidine. Each animal received 500 metacercariae orally. The experimental infection was confirmed histologically, by detection of Fasciola eggs in faeces and by measuring the activities of the enzymes sorbitol dehydrogenase (SD), glutamate dehydrogenase (GD) and aspartate aminotransferase (AST) in plasma during the course of the disease. Changes in the pharmacokinetics of antipyrine and sulphadimidine were reported in the experimentally infected animals. Significant prolongation of antipyrine half life was observed 16 weeks after infection. The half-life of sulphadimidine was also significantly prolonged 5, 9 and 16 weeks after infection. Clearance of the sulphonamide was decreased significantly 5 and 9 weeks after infection and it regained its pre-infection value 16 weeks after infection.
AuthorsH A Elsheikh, B H Ali
JournalJournal of veterinary pharmacology and therapeutics (J Vet Pharmacol Ther) Vol. 20 Issue 3 Pg. 167-72 (Jun 1997) ISSN: 0140-7783 [Print] England
PMID9185081 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Sulfanilamides
  • sulfamethomidine
  • Antipyrine
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (blood, pharmacokinetics)
  • Antipyrine (blood, pharmacokinetics)
  • Area Under Curve
  • Fascioliasis (enzymology, metabolism)
  • Half-Life
  • Male
  • Metabolic Clearance Rate
  • Sheep
  • Sulfanilamides (blood, pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: